关注
Sara Ferluga
Sara Ferluga
Oxford BioMedica
在 oxb.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
OryR Is a LuxR-Family Protein Involved in Interkingdom Signaling between Pathogenic Xanthomonas oryzae pv. oryzae and Rice
S Ferluga, V Venturi
Journal of bacteriology 191 (3), 890-897, 2009
1192009
A LuxR homologue of Xanthomonas oryzae pv. oryzae is required for optimal rice virulence
S Ferluga, J Bigirimana, M Höfte, V Venturi
Molecular plant pathology 8 (4), 529-538, 2007
1072007
The plant pathogen Pseudomonas fuscovaginae contains two conserved quorum sensing systems involved in virulence and negatively regulated by RsaL and the …
M Mattiuzzo, I Bertani, S Ferluga, L Cabrio, J Bigirimana, C Guarnaccia, ...
Environmental microbiology 13 (1), 145-162, 2011
892011
Simultaneous targeting of Eph receptors in glioblastoma
S Ferluga, CML Tomé, DM Herpai, R D'Agostino, W Debinski
Oncotarget 7 (37), 59860, 2016
612016
Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism
J Dunn, S Ferluga, V Sharma, M Futschik, DA Hilton, CL Adams, ...
EBioMedicine 40, 77-91, 2019
522019
Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase
S Ferluga, R Hantgan, Y Goldgur, JP Himanen, DB Nikolov, W Debinski
Journal of Biological Chemistry 288 (25), 18448-18457, 2013
522013
Structural and functional characterization of monomeric EphrinA1 binding site to EphA2 receptor
CML Tomé, E Palma, S Ferluga, WT Lowther, R Hantgan, J Wykosky, ...
Journal of Biological Chemistry 287 (17), 14012-14022, 2012
372012
Ephs and Ephrins in malignant gliomas
S Ferluga, W Debinski
Growth Factors 32 (6), 190-201, 2014
352014
Global proteome and phospho-proteome analysis of merlin-deficient meningioma and schwannoma identifies PDLIM2 as a novel therapeutic target
K Bassiri, S Ferluga, V Sharma, N Syed, CL Adams, E Lasonder, ...
EBioMedicine 16, 76-86, 2017
342017
Lipopolysaccharide phosphorylation by the WaaY kinase affects the susceptibility of Escherichia coli to the human antimicrobial peptide LL-37
K Bociek, S Ferluga, M Mardirossian, M Benincasa, A Tossi, R Gennaro, ...
Journal of Biological Chemistry 290 (32), 19933-19941, 2015
322015
N-Acyl Homoserine Lactone Quorum Sensing in Gram-Negative Rhizobacteria
S Ferluga, L Steindler, V Venturi
Secondary metabolites in soil ecology, 69-90, 2008
292008
Constitutive activation of the EGFR–STAT1 axis increases proliferation of meningioma tumor cells
S Ferluga, D Baiz, DA Hilton, CL Adams, E Ercolano, J Dunn, K Bassiri, ...
Neuro-oncology advances 2 (1), vdaa008, 2020
212020
A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated …
CL Adams, E Ercolano, S Ferluga, A Sofela, F Dave, C Negroni, ...
International Journal of Molecular Sciences 21 (4), 1273, 2020
202020
EPHA3 and multi-valent targeting of tumors
W Debinski, CL Tome, S Ferluga, PS Sonawane
US Patent 10,752,667, 2020
12020
BI-09EphA3 RECEPTOR IS A MOLECULAR TARGET EXPRESSED IN MULTIPLE COMPARTMENTS OF GBM
S Ferluga, D Gibo, W Debinski
Neuro-oncology 16 (Suppl 5), v25, 2014
12014
Glycosylation is indispensable for ephrin A1 activity
S Ferluga, W Debinski
Cancer Research 72 (8_Supplement), 3860-3860, 2012
12012
Epha3 and multi-valent targeting of tumors
W Debinski, CL Tome, S Ferluga, PS Sonawane
US Patent App. 18/316,672, 2023
2023
EPHA3 and multi-valent targeting of tumors
W Debinski, CL Tome, S Ferluga, PS Sonawane
US Patent 11,697,675, 2023
2023
miR-9-1 Is a New Circulating Biomarker for Higher-grade Meningioma Regulated via the EGFR-FOS Network
D Baiz, C Negroni, S Ferluga, E Ercolano, CL Adams, A Sofela, DA Hilton, ...
2020
A Rapid Robust Method for Subgrouping Non-NF2 Meningiomas According to Genotype and Detection of Lower Levels of M2 Macrophages in AKT1 E17K Mutated Tumours
E Ercolano, S Ferluga, A Sofela, F Dave
2020
系统目前无法执行此操作,请稍后再试。
文章 1–20